Capricor Therapeutics, Inc. (CAPR) financial statements (2022 and earlier)

Company profile

Business Address 8840 WILSHIRE BLVD
BEVERLY HILLS, CA 90211
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments34,88532,6669,8857,25614,12516,19513,567
Cash and cash equivalents34,88532,6663,8994,2596,1403,2045,568
Short-term investments  5,9862,9977,98512,9917,999
Restricted cash and investments   2867421,347 
Receivables392 88205345223212
Other undisclosed current assets1,1601,011571724501343211
Total current assets:36,43733,67710,5458,47115,71318,10813,990
Noncurrent Assets
Operating lease, right-of-use asset2,822  
Property, plant and equipment1,796851443574372435319
Intangible assets, net (including goodwill)(260)2650931421,691
Intangible assets, net (excluding goodwill)(260)2650931421,691
Deferred costs      30
Other undisclosed noncurrent assets53589120152966140
Total noncurrent assets:4,8939425697765616392,080
TOTAL ASSETS:41,33034,61911,1149,24716,27418,74716,070
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:3,1162,7258761,1491,4963,0392,531
Other undisclosed accounts payable and accrued liabilities3,1162,7258761,1491,4963,0392,531
Debt 247     
Deferred revenue and credits 1,3673,646
Other undisclosed current liabilities1,017 22106174489352
Total current liabilities:4,1332,9718981,2551,6714,8956,529
Noncurrent Liabilities
Long-term debt and lease obligation2,45371   13,9069,156
Long-term debt, excluding current maturities 71   13,9069,156
Operating lease, liability2,453  
Liabilities, other than long-term debt      911
Deferred revenue and credits  911
Other undisclosed noncurrent liabilities9243,3763,3763,3763,3763,949505
Total noncurrent liabilities:5,8293,4483,3763,3763,37617,85510,573
Total liabilities:9,9626,4194,2744,6315,04722,75117,101
Stockholders' equity
Stockholders' equity attributable to parent31,36828,2006,8394,61611,227(4,003)(1,032)
Common stock2421531262116
Additional paid in capital139,404116,21781,21671,31162,73749,95134,115
Accumulated other comprehensive income (loss)  (1)121249
Accumulated deficit(108,060)(88,038)(74,381)(66,739)(51,548)(53,979)(35,172)
Total stockholders' equity:31,36828,2006,8394,61611,227(4,003)(1,032)
TOTAL LIABILITIES AND EQUITY:41,33034,61911,1149,24716,27418,74716,070

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues2453101,0051,6712,6663,9995,518
Revenue, net1,2998091,742
Other income548      
Gross profit:2453101,0051,6712,6663,9995,518
Operating expenses(21,183)(14,000)(8,739)(16,998)(15,529)(20,975)(18,129)
Operating loss:(20,938)(13,690)(7,734)(15,327)(12,862)(16,977)(12,612)
Nonoperating income (expense)916339213615,294(1,830)(246)
Investment income, nonoperating57339513638143
Interest and debt expense    (399)(345)(249)
Net income (loss):(20,023)(13,657)(7,642)(15,191)2,033(19,151)(13,106)
Other undisclosed net income attributable to parent    399345249
Net income (loss) available to common stockholders, diluted:(20,023)(13,657)(7,642)(15,191)2,431(18,807)(12,857)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):(20,023)(13,657)(7,642)(15,191)2,033(19,151)(13,106)
Comprehensive income (loss):(20,023)(13,657)(7,642)(15,191)2,033(19,151)(13,106)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent 1(13)1407339258
Comprehensive income (loss), net of tax, attributable to parent:(20,023)(13,656)(7,655)(15,190)2,440(18,813)(12,848)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: